Screening for cognitive impairment in older adults attending an eye clinic

Journal of the National Medical Association

Volumn 97, Issue 6, 2005, Pages 808-814

  Raji, Mukaila A ^a,d   Tang, Rosa A ^a   Heyn, Patricia C ^b   Kuo, Yong Fang ^a   Owen, Steven V ^c   Singh, Sonali ^a   Ottenbacher, Kenneth J ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cognitive impairment; Older adults; Visual impairments

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CAUCASIAN; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; HEALTH CENTER; HISPANIC; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT INFORMATION; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SOCIAL ASPECT; ST LOUIS UNIVERSITY MENTAL STATUS EXAMINATION; SYSTOLIC BLOOD PRESSURE; VISUAL ACUITY; VISUAL IMPAIRMENT;

AFRICAN AMERICANS; AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; EYE DISEASES; FEMALE; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; OUTPATIENT CLINICS, HOSPITAL; PREVALENCE;

EID: 20344365824     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
2. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 1997;349:151-154.
3. Kalmijn S, Foley L, White CM, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia Aging Study. Arterioscler Thromb Vacs Biol. 2000;20:2255-2260.
4. Landin K, Blennow K, Wallin A, et al. Low blood pressure and blood glucose levels in Alzheimer's disease: evidence for a hypometabolic disorder? J Inter Med. 1993;233:357-363.
5. Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol. 1997;42:776-782.
6. Sparks DL. Coronary artery disease, hypertension, apo E and cholesterol: a link to Alzheimer's disease? Ann NY Acad Sci. 1997;826:128-146.
7. Nestor PJ, Scheltens P, Hodges JR. Advances in the early detection of Alzheimer's disease. Nat Rev Neurosci. 2004;Suppl(5):S34-S41.
8. Guralnik JM. The impact of vision and hearing impairments on health in old age [editorial]. J Am Geriatr Soc. 1999;47:1029-1031.
9. Duffy CJ. Visual loss in Alzheimer's disease. Out of sight, out of mind. Neurology. 1999;52:10-11.
10. Giannakopoulos P, Gold G, Duc M, et al. Neuroanatomic correlates of visual agnosia in Alzheimer's disease: a clinicopathologic study. Neurology. 1999;52:71-77.
11. Kiyosawa M, Bosley TM, Chawluk J, et al. Alzheimer's disease with prominent visual symptoms. Ophthalmology. 1989;96:1077-1086.
12. Levine DN, Lee JM, Fisher CM. The visual variant of Alzheimer's disease. Neurology 1993;43:305-313.
13. Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer's disease. Ophthalmology 1990;97:9-17.
14. Sadun AA, Borchert M, DeVita E, et al. Assessment of visual impairment in patients with Alzheimer's disease. Am J Ophthalmology. 1987;104:113-120.
15. Trick GL, Trick LR, Morris P, et al. Visual field loss in senile dementia of the Alzheimer's type. Neurology. 1995;45:68-74.
16. Warren S, Hier DB, Pavel D. Visual form of Alzheimer's disease and its response to anticholinesterase therapy. J Neuroimaging. 1998;8:249-252.
17. Barbeau E, Didic M, Tramoni E, et al. Evaluation of visual recognition memory in MCI patients. Neurology. 2004;62:1317-1322.
18. Lee AG, Beaver HA, Jogerst G, et al. Screening elderly patients in an outpatient ophthalmology clinic for dementia, depression and functional impairment. Ophthalmology. 2003;110:651-657.
19. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325: 1412-1427.
20. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;226:369-374.
21. Banks WA, Morley JE. Memories are made of this: recent advances in understanding cognitive impairments and dementia. J Gerontol A: Biol Sci Med Sci. 2003;58:314-321.
22. Tariq SH, Tumosa N, Chibnall JT, et al. The Saint Louis University mental Status (SLUMS) Examination is more sensitive than Mini-Mental State Examination (MMSE) for detecting mild cognitive impairment (MCI) and dementia. J Am Geriatr Soc. 2004;52(4):122 Suppl.
23. Washburn RA, Smith KW, Jette AM, et al. The Physical Activity Scale for the Elderly (PASE): development and Evaluation. J Clin Epidemiol. 1993; 46:153-162.
24. Demirovic J, Prineas R, Loewenstein D, et al. Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. J Ann Epidemiol. 2003;13:472-478.
25. Grigsby J, Kaye K, Shetterly SM, et al. Prevalence of disorders of executive cognitive functioning among the elderly: findings from the San Luis Valley Health and Aging Study. Neuroepidemiology. 2002;21:213-220.
26. Boise L, Neal NB, Kaye J. Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol Med Sci. 2004; 59A:621-626.
27. Parker C, Philp I. Screening for cognitive impairment among older people in black and minority ethnic groups. Age Ageing. 2004;33:447-452.
28. Fontbonne A, Berr C, Ducimetiere P, et al. Changes in cognitive abilities over a four-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care. 2001;24:366-370.
29. Grodstein F, Chen J, Wilson RS, et al. Nurses' Health Study. Type-2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care. 2001;24:1000-1065.
30. Lindeman RD, Romero LJ, LaRue A, et al. New Mexico Elder Health Survey. A biethnic community survey of cognition in participants with type-2 diabetes, impaired glucose tolerance and normal glucose tolerance: the New Mexico Elder Health Survey. Diabetes Care. 2001;24:1567-1572.
31. Allen KV, Frier BM, Strachan MW. The relationship between type-2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol. 2004;490:169-175.
32. Taubes G. Neuroscience. Insulin insults may spur Alzheimer's disease. Science. 2003;301:40-41.